Supplement Science Corp. d/b/a Condemned Labz was cited for distributing unapproved new drugs and misbranded products, including Arsyn, ConvictStim, Humaslin, Thyrogenic, and DNA Dispatch, through their website and Facebook page. The company made disease claims on their marketing materials—such as "reduces blood sugar levels" and "optimizes insulin sensitivity" for Humaslin, and "increases tolerance to pain" for DNA Dispatch—that established these products as drugs under federal law without obtaining FDA approval. These marketing practices and introduction of the unapproved products into interstate commerce violated the Federal Food, Drug, and Cosmetic Act. The FDA's review occurred across multiple months in 2021 and included examination of both the company's main website and social media platforms directing consumers to purchase these products.